ACUSHNET HOLDINGS CORP., 10-Q filed on 5/6/2026
Quarterly Report
v3.26.1
Cover Page - shares
3 Months Ended
Mar. 31, 2026
Apr. 30, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-37935  
Entity Registrant Name Acushnet Holdings Corp.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 45-2644353  
Entity Address, Address Line One 333 Bridge Street  
Entity Address, City or Town Fairhaven,  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02719  
City Area Code 800  
Local Phone Number 225-8500  
Title of 12(b) Security Common Stock - $0.001 par value per share  
Trading Symbol GOLF  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   58,554,053
Entity Central Index Key 0001672013  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash, cash equivalents and restricted cash ($852 and $0 attributable to a variable interest entity ("VIE")) $ 51,679 $ 50,088
Accounts receivable, net 504,764 217,480
Inventories ($3,411 and $0 attributable to a VIE) 576,722 608,571
Prepaid and other current assets 162,130 149,232
Total current assets 1,295,295 1,025,371
Property, plant and equipment, net 360,078 356,575
Goodwill 223,056 224,258
Intangible assets, net 509,156 511,430
Deferred income taxes 14,252 21,081
Other assets 198,065 203,984
Total assets 2,599,902 2,342,699
Current liabilities    
Short-term debt 27,962 16,005
Current portion of long-term debt 650 661
Accounts payable ($2,849 and $0 attributable to a VIE) 179,561 156,984
Accrued taxes 47,182 34,219
Accrued compensation and benefits 66,028 100,975
Accrued expenses and other liabilities 130,629 121,310
Total current liabilities 452,012 430,154
Long-term debt 1,122,410 926,244
Deferred income taxes 11,881 7,604
Accrued pension and other postretirement benefits 67,000 68,756
Other noncurrent liabilities ($1,500 and $0 attributable to a VIE) 119,969 124,605
Total liabilities 1,773,272 1,557,363
Commitments and contingencies (Note 15)
Redeemable noncontrolling interests 1,595 1,770
Shareholders' equity    
Common stock, $0.001 par value, 500,000,000 shares authorized; 58,548,082 and 58,371,822 shares issued 59 58
Additional paid-in capital 751,491 763,828
Accumulated other comprehensive loss, net of tax (125,603) (122,281)
Retained earnings 199,165 141,961
Total equity attributable to Acushnet Holdings Corp. 825,112 783,566
Noncontrolling interests (77) 0
Total shareholders' equity 825,035 783,566
Total liabilities, redeemable noncontrolling interests and shareholders' equity $ 2,599,902 $ 2,342,699
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Cash, cash equivalents and restricted cash $ 51,679 $ 50,088
Inventories 576,722 608,571
Accounts payable 179,561 156,984
Other noncurrent liabilities $ 119,969 $ 124,605
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 58,548,082 58,371,822
VIE    
Cash, cash equivalents and restricted cash $ 852 $ 0
Inventories 3,411 0
Accounts payable 2,849 0
Other noncurrent liabilities $ 1,500 $ 0
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net sales $ 752,975 $ 703,372
Cost of goods sold 397,715 366,210
Gross profit 355,260 337,162
Operating expenses:    
Selling, general and administrative 213,671 200,261
Research and development 19,195 18,859
Intangible amortization 2,245 3,495
Income from operations 120,149 114,547
Interest expense, net 13,072 13,815
Other expense (income), net 1,816 (19,863)
Income before income taxes 105,261 120,595
Income tax expense 24,101 21,570
Net income 81,160 99,025
Less: Net loss attributable to noncontrolling interests 256 347
Net income attributable to Acushnet Holdings Corp. $ 81,416 $ 99,372
Net income per common share attributable to Acushnet Holdings Corp.:    
Basic (in dollars per share) $ 1.36 $ 1.62
Diluted (in dollars per share) $ 1.36 $ 1.62
Weighted average number of common shares:    
Basic (in shares) 59,845,676 61,325,623
Diluted (in shares) 60,009,105 61,484,788
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net income $ 81,160 $ 99,025
Other comprehensive (loss) income:    
Foreign currency translation adjustments (6,297) 8,894
Cash flow derivative instruments:    
Unrealized holding gains (losses) arising during period 2,679 (2,160)
Reclassification adjustments included in net income 498 (414)
Tax (expense) benefit (794) 739
Cash flow derivative instruments, net 2,383 (1,835)
Pension and other postretirement benefits:    
Pension and other postretirement benefits adjustments 776 (645)
Tax (expense) benefit (183) 127
Pension and other postretirement benefits adjustments, net 593 (518)
Total other comprehensive (loss) income (3,321) 6,541
Comprehensive income 77,839 105,566
Less: Comprehensive loss attributable to noncontrolling interests 255 269
Comprehensive income attributable to Acushnet Holdings Corp. $ 78,094 $ 105,835
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ 81,160 $ 99,025
Adjustments to reconcile net income to cash flows used in operating activities    
Depreciation and amortization 12,869 14,277
Unrealized foreign exchange loss (gain) 1,923 (2,085)
Amortization of debt issuance costs 329 452
Share-based compensation 8,580 6,941
Loss on disposals of property, plant and equipment 30 385
Gain on deconsolidation of VIE (Note 16) 0 (20,887)
Loss from equity method investment (Note 16) 66 223
Deferred income taxes 9,712 4,885
Changes in operating assets and liabilities    
Accounts receivable (290,737) (254,549)
Inventories 27,916 42,496
Accounts payable 27,996 35,926
Accrued taxes 14,005 14,483
Other assets and liabilities (37,512) (61,826)
Cash flows used in operating activities (143,663) (120,254)
Cash flows from investing activities    
Additions to property, plant and equipment (19,191) (11,263)
Cash flows used in investing activities (19,191) (11,263)
Cash flows from financing activities    
Proceeds from credit facilities (Note $5) 444,524 401,522
Repayments of credit facilities (Note $5) (235,598) (223,230)
Purchases of common stock (9,977) (35,683)
Dividends paid on common stock (15,874) (14,778)
Payment of employee restricted stock tax withholdings (19,667) (9,686)
Other, net 1,500 0
Cash flows provided by financing activities 164,908 118,145
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash (463) 912
Net increase (decrease) in cash, cash equivalents and restricted cash 1,591 (12,460)
Cash, cash equivalents and restricted cash, beginning of year 50,088 53,059
Cash, cash equivalents and restricted cash, end of period 51,679 40,599
Supplemental non-cash information    
Purchases of property, plant and equipment, accrued not paid 4,283 2,439
Additions to right-of-use assets obtained in exchange for operating lease obligations 2,502 5,345
Dividend equivalents rights ("DERs") declared not paid 646 506
Additions to share repurchase liability (Note 10) 0 36,637
Additional investment in less than wholly-owned subsidiary (Note 16) $ 6,361 $ 0
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     61,215          
Beginning balance at Dec. 31, 2024 $ 793,136 $ 765,247 $ 61 $ 787,725 $ (140,315) $ 180,276 $ (62,500) $ 27,889
Changes in stockholders' equity                
Net income (loss) 99,184 99,372       99,372   (188)
Other comprehensive income 6,463 6,463     6,463      
Share-based compensation 6,941 6,941   6,941        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     247          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (9,686) (9,686)   (9,686)        
Purchases of common stock (Note 10) (in shares)     (541)          
Purchases of common stock (Note 10) (36,840) (36,840)   (6,909)   (29,931)    
Share repurchase liability (Note 10) (36,637) (36,637)         (36,637)  
Dividends and dividend equivalents declared (14,576) (14,576)       (14,576)    
Deconsolidation of VIE (Note 1) (27,701)             (27,701)
Ending balance (in shares) at Mar. 31, 2025     60,921          
Ending balance at Mar. 31, 2025 780,284 780,284 $ 61 778,071 (133,852) 235,141 (99,137) 0
Beginning balance (in shares) at Dec. 31, 2024     61,215          
Beginning balance at Dec. 31, 2024 793,136 765,247 $ 61 787,725 (140,315) 180,276 (62,500) 27,889
Changes in stockholders' equity                
Dividends and dividend equivalents declared (57,374)              
Ending balance (in shares) at Dec. 31, 2025     58,372          
Ending balance at Dec. 31, 2025 783,566 783,566 $ 58 763,828 (122,281) 141,961 0 0
Changes in stockholders' equity                
Capital contribution from noncontrolling interests (Note 16) 3             3
Net income (loss) 81,336 81,416       81,416   (80)
Other comprehensive income (3,322) (3,322)     (3,322)      
Share-based compensation 8,580 8,580   8,580        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     282          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (19,556) (19,556) $ 1 (19,557)        
Purchases of common stock (Note 10) (in shares)     (106)          
Purchases of common stock (Note 10) (9,977) (9,977)   (1,360)   (8,617)    
Dividends and dividend equivalents declared (15,595) (15,595)       (15,595)    
Ending balance (in shares) at Mar. 31, 2026     58,548          
Ending balance at Mar. 31, 2026 $ 825,035 $ 825,112 $ 59 $ 751,491 $ (125,603) $ 199,165 $ 0 $ (77)
v3.26.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of Acushnet Holdings Corp. (the “Company”) have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). These unaudited condensed consolidated financial statements include the accounts of the Company and Acushnet Company, including Acushnet Company's wholly-owned subsidiaries and less than wholly-owned subsidiaries, which include VIEs in which Acushnet Company is the primary beneficiary. In addition, investments in entities over which the Company has significant influence but not control are accounted for using the equity method of accounting. The Company conducts substantially all its business through Acushnet Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the SEC and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of results to be expected for the full year ending December 31, 2026, nor were those of the comparable 2025 periods representative of those actually experienced for the full year ended December 31, 2025. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2025 included in its Annual Report on Form 10-K filed with the SEC on February 27, 2026.
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities
VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company presents separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of consolidated VIEs that can only be used to settle specific obligations of the consolidated VIEs and the liabilities of consolidated VIEs for which creditors do not have recourse to its general credit. See Note 16 for additional information regarding other business developments impacting VIEs.
Equity Method Investments
The Company uses the equity method of accounting for equity investments if the investment enables the Company to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in consolidated net income (loss). The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. An impairment that is other-than-temporary is recognized in the period identified. See Note 16 for additional information regarding other business developments impacting equity method investments.
Noncontrolling Interests and Redeemable Noncontrolling Interests
The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders was $4.4 million as of both March 31, 2026 and December 31, 2025. See Note 16 for additional information regarding other business developments impacting noncontrolling interests.
Cash, Cash Equivalents and Restricted Cash
Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of March 31, 2026 and December 31, 2025, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $1.3 million and $1.4 million, respectively.
Foreign Currency Transactions
Foreign currency transaction (losses) gains included in selling, general and administrative expenses were losses of $1.8 million and gains of $1.4 million for the three months ended March 31, 2026 and 2025, respectively.
Recently Issued Accounting Standards
Expense Disaggregation Disclosures
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)." The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
Codification Improvements
In December 2025, the FASB issued ASU 2025-12, "Codification Improvements." The amendments in this update refine existing guidance to further enhance the interpretation and application of the codification. The transition method of this update may vary on an issue-by-issue basis. ASU 2025-12 is effective for annual and interim periods beginning after December 15, 2026. Early adoption is permitted on an issue-by-issue basis. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
v3.26.1
Allowance for Credit Losses
3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Allowance for Credit Losses Allowance for Credit Losses
The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current economic conditions, which could affect the collectability of the reported amounts. All these factors have been considered in the estimate of expected credit losses for the periods presented.
The activity related to the allowance for credit losses was as follows:
March 31,
(in thousands)20262025
Balance at beginning of period$7,319 $7,238 
Decrease in provision for expected credit losses(1,290)(920)
Amount of receivables (written off) recovered(149)91 
Foreign currency translation(31)124 
Balance at end of period$5,849 $6,533 
v3.26.1
Inventories
3 Months Ended
Mar. 31, 2026
Inventory Disclosure [Abstract]  
Inventories Inventories
The components of inventories were as follows: 
March 31,December 31,
(in thousands)20262025
Raw materials and supplies$162,492 $145,663 
Work-in-process33,446 31,570 
Finished goods380,784 431,338 
Inventories$576,722 $608,571 
v3.26.1
Product Warranty
3 Months Ended
Mar. 31, 2026
Product Warranties Disclosures [Abstract]  
Product Warranty Product Warranty
The Company has defined warranties generally ranging from one to two years. Products covered by the defined warranty policies primarily include all Titleist golf products, FootJoy golf shoes and FootJoy golf outerwear. These product warranties generally obligate the Company to pay for the cost of replacement products, including the cost of shipping replacement products to its customers. The estimated cost of satisfying future warranty claims is accrued at the time the sale is recorded. In estimating future warranty obligations, the Company considers various factors, including its warranty policies and practices, the historical frequency of claims and the cost to replace or repair products under warranty.
The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:
 March 31,
(in thousands)20262025
Balance at beginning of period$6,062 $4,980 
Provision2,002 1,441 
Claims paid/costs incurred(1,635)(1,266)
Foreign currency translation(53)35 
Balance at end of period$6,376 $5,190 
v3.26.1
Debt and Financing Arrangements
3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Debt and Financing Arrangements Debt and Financing Arrangements
Multi-Currency Revolving Credit Facility
The Company's credit agreement, dated as of December 23, 2019, as subsequently amended (the "Credit Agreement"), provides for a $950.0 million multi-currency revolving credit facility, due to mature on November 24, 2030. The Credit Agreement, together with related security, guarantee and other agreements, is referred to as the “Revolving Credit Facility.”
The Credit Agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The Credit Agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2026, the Company was in compliance with all covenants under the Credit Agreement.
As of March 31, 2026 and December 31, 2025, there were $627.6 million and $431.3 million, respectively, in outstanding borrowings under the Revolving Credit Facility, with a weighted average interest rate of 4.91% and 5.06%, respectively. As of March 31, 2026, the Company had available borrowing capacity under the Revolving Credit Facility of $318.4 million after giving effect to $4.0 million of outstanding letters of credit.
Senior Notes
As of March 31, 2026 and December 31, 2025, Acushnet Company had 5.625% senior unsecured notes due December 1, 2033 (the "Notes") outstanding in the aggregate principal balance of $500.0 million. The fair value of the Notes, based on third-party quotes (Level 2), as of March 31, 2026 and December 31, 2025 was $495.8 million and $505.0 million, respectively.
The Notes bear interest at a stated interest rate of 5.625% (an effective interest rate of 5.788%) per year, with interest payable semi-annually on June 1 and December 1 of each year. Accrued interest related to the Notes of $9.9 million and $2.9 million was included within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025, respectively.
The indenture that governs the Notes (the "Indenture") contains covenants that, among other things, limit the ability of the Company and its subsidiaries to incur liens securing indebtedness for borrowed money, enter into sale and leaseback transactions, and consolidate or merge with or into other companies. As of March 31, 2026, the Company was in compliance with all covenants under the Indenture.
Other Short-Term Borrowings
The Company has certain unsecured and uncommitted local credit facilities available through its subsidiaries. Amounts outstanding under these other short-term borrowings are presented in short-term debt in the unaudited condensed consolidated balance sheets with the proceeds and repayments presented on a gross basis in the unaudited condensed consolidated statements of cash flows. There were $28.0 million and $16.0 million in outstanding borrowings under the Company's local credit facilities as of March 31, 2026 and December 31, 2025, respectively. The weighted average interest rate applicable to the outstanding borrowings was 1.37% and 0.88% as of March 31, 2026 and December 31, 2025, respectively. As of March 31, 2026, the Company had available borrowing capacity under these local credit facilities of $24.8 million.
Letters of Credit
As of March 31, 2026 and December 31, 2025, there were outstanding letters of credit related to agreements, including those issued under the Revolving Credit Facility, totaling $6.8 million and $6.9 million, respectively, of which $4.0 million was secured as of both March 31, 2026 and December 31, 2025. These agreements provided a maximum commitment for letters of credit of $58.8 million as of March 31, 2026.
v3.26.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes.
Foreign Exchange Derivative Instruments
Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won, the Australian dollar and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2026 and December 31, 2025 was $257.8 million and $230.7 million, respectively.
Impact on Financial Statements
The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:
(in thousands)March 31,December 31,
Balance Sheet LocationHedge Instrument Type20262025
Prepaid and other current assetsForeign exchange forward$4,881 $2,950 
Accrued expenses and other liabilitiesForeign exchange forward1,360 1,746 
The hedge instrument gains (losses) recognized in accumulated other comprehensive loss, net of tax was as follows:
 Three months ended
 March 31,
(in thousands)20262025
Type of hedge  
Foreign exchange forward$2,679 $(2,160)
 Total$2,679 $(2,160)
Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net gain of $3.7 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12.
The hedge instrument gains (losses) recognized on the unaudited condensed consolidated statements of operations were as follows:
 Three months ended
 March 31,
(in thousands)20262025
Location of gains (losses) in statements of operations  
Foreign exchange forward:
Cost of goods sold$(498)$411 
Selling, general and administrative (1)
816 (960)
Total $318 $(549)
_______________________________________________________________________________
(1) Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.
Credit Risk
The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.
v3.26.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2026 were as follows:
 Fair Value Measurements as of 
 March 31, 2026 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$2,771 $— $— Prepaid and other current assets
Foreign exchange derivative instruments— 4,881 — Prepaid and other current assets
Deferred compensation program assets687 — — Other assets
Total assets$3,458 $4,881 $—  
Liabilities    
Foreign exchange derivative instruments$— $1,360 $— Accrued expenses and other liabilities
Deferred compensation program liabilities687 — — Other noncurrent liabilities
Total liabilities$687 $1,360 $—  
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 were as follows:
 Fair Value Measurements as of 
 December 31, 2025 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$2,906 $— $— Prepaid and other current assets
Foreign exchange derivative instruments— 2,950 — Prepaid and other current assets
Deferred compensation program assets719 — — Other assets
Total assets$3,625 $2,950 $—  
Liabilities    
Foreign exchange derivative instruments$— $1,746 $— Accrued expenses and other liabilities
Deferred compensation program liabilities719 — — Other noncurrent liabilities
Total liabilities$719 $1,746 $—  
Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds.
Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011.
Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company used the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period.
v3.26.1
Pension and Other Postretirement Benefits
3 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Pension and Other Postretirement Benefits
Components of net periodic benefit cost (credit) were as follows: 
 Pension BenefitsPostretirement Benefits
 Three months ended March 31,
(in thousands)2026202520262025
Components of net periodic benefit cost (credit)    
Service cost$1,045 $1,279 $89 $90 
Interest cost2,599 2,892 129 143 
Expected return on plan assets(1,758)(2,017)— — 
Settlement expense682 — — — 
Amortization of net loss (gain)100 67 (200)(237)
Amortization of prior service cost (credit)18 22 — (1)
Net periodic benefit cost (credit)$2,686 $2,243 $18 $(5)
The non-service cost components of net periodic benefit cost (credit) are included in other expense (income), net in the unaudited condensed consolidated statements of operations.
v3.26.1
Income Taxes
3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income tax expense increased by $2.5 million to $24.1 million for the three months ended March 31, 2026 compared to $21.6 million for the three months ended March 31, 2025. The Company’s effective income tax rate ("ETR") was 22.9% for the three months ended March 31, 2026 compared to 17.9% for the three months ended March 31, 2025.
The ETR for the three months ended March 31, 2026 differed from the U.S. statutory tax rate primarily due to the U.S taxation of foreign income, state income taxes and the Company's jurisdictional mix of earnings, partially offset by the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits. The ETR for the three months ended March 31, 2025 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, partially offset by the U.S. taxation of foreign income, state income taxes and the Company's jurisdictional mix of earnings.
v3.26.1
Common Stock
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Common Stock Common Stock
Dividends
The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:
Dividends per Common Share
Amount
(in thousands)
2026:
First Quarter$0.255 $15,595 
Total dividends declared in 2026$0.255 $15,595 
2025:
Fourth Quarter$0.235 $14,112 
Third Quarter0.235 14,388 
Second Quarter0.235 14,298 
First Quarter0.235 14,576 
Total dividends declared in 2025$0.940 $57,374 
During the second quarter of 2026, the Company's board of directors declared a dividend of $0.255 per share of common stock to shareholders of record as of June 5, 2026 and payable on June 22, 2026.
Share Repurchase Program
As of March 31, 2026, the board of directors had authorized the Company to repurchase up to $1.25 billion of its issued and outstanding common stock since the share repurchase program was established in 2018. This program may be extended or otherwise modified by the board of directors at any time and will remain in effect until completed or until terminated by the board of directors. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Credit Agreement (Note 5).
On June 14, 2024, the Company entered into an agreement with Magnus Holdings Co., Ltd. ("Magnus"), to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from July 1, 2024 through December 31, 2024, up to an aggregate of $62.5 million, at the same weighted average per share price (the "June 2024 Agreement"). On April 10, 2025, the Company purchased 935,907 shares of its common stock from Magnus for an aggregate of $62.5 million in satisfaction of its obligation under the June 2024 Agreement.
On December 17, 2024, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from January 2, 2025 through June 30, 2025, up to an aggregate of $62.5 million, at the same weighted average per share price (the "December 2024 Agreement"). On July 10, 2025, the Company purchased 953,406 shares of its common stock from Magnus for an aggregate of $62.5 million in satisfaction of its obligation under the December 2024 Agreement.
The Company's share repurchase activity for the periods presented was as follows:
Three months ended March 31,
(in thousands, except share and per share amounts)20262025
Shares repurchased in the open market:
Shares repurchased 106,008 540,944 
Average price$94.12 $67.73 
Aggregate value (1)
$9,977 $36,637 
Total shares repurchased:
Shares repurchased106,008 540,944 
Average price$94.12 $67.73 
Aggregate value$9,977 $36,637 
___________________________________
(1) Includes $1.0 million related to shares repurchased not settled as of the three months ended March 31, 2025.
As of March 31, 2026, the Company had $230.7 million remaining under the current share repurchase authorization.
Common Stock Retirement
The Company records retirements of repurchased common stock, upon either formal or constructive retirement, at cost and allocates the excess of the repurchase price over the par value of shares acquired to both retained earnings and additional paid-in capital. The portion allocated to additional paid-in capital is calculated on a pro rata basis of the shares to be retired and the total shares issued and outstanding as of the date of retirement. When shares of common stock are retired, they are deducted from the number of shares issued.
As of March 31, 2026, the Company presented as retired 106,008 shares of its repurchased common stock with an aggregate repurchase price of $10.0 million, which the Company intends to formally retire in 2026.
v3.26.1
Equity Incentive Plans
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
Under the Acushnet Holdings Corp. Amended and Restated 2015 Omnibus Incentive Plan (the “Amended and Restated 2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the board of directors, officers, employees, consultants and advisors of the Company. As of March 31, 2026, the only equity-based awards granted under the Amended and Restated 2015 Plan were RSUs and PSUs.
As of March 31, 2026, there were 5,725,693 remaining shares of common stock reserved for issuance under the Amended and Restated 2015 Plan of which 3,120,170 remained available for future grants.
Restricted Stock and Performance Stock Units
RSUs granted to members of the board of directors vest immediately into shares of common stock. RSUs granted to the officers, employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally over three years, with one-third of each grant vesting annually, subject to the recipient’s continued service to the Company. PSUs granted to Company officers and other employees vest based upon the Company's performance against specified targets, generally over a three-year performance period, subject to the recipient's continued service to the Company. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these targets. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the Amended and Restated 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient.
All RSUs and PSUs granted under the Amended and Restated 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered.
A summary of the Company’s RSUs and PSUs as of March 31, 2026 and changes during the three months then ended is presented below: 
 Weighted-Weighted-
 NumberAverageNumberAverage
 of RSUsFair Value RSUs
of PSUs (3)
Fair Value PSUs
Outstanding as of December 31, 2025603,148 $65.08 500,371 $60.05 
Granted219,875 99.99 119,704 100.01 
Vested (1)(2)
(306,015)60.68 (193,351)48.21 
Forfeited(515)67.73 — — 
Outstanding as of March 31, 2026516,493 $82.55 426,724 $76.62 

_______________________________________________________________________________
(1) Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 193,351 PSUs that vested during the three months ended March 31, 2026, were entitled to receive 241,882 shares of common stock.
(2) Included 26,195 and 67,041 shares of common stock related to RSUs and PSUs, respectively, that were not delivered as of March 31, 2026.
(3) Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved.
Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20262025
RSUs$4,765 $5,032 
PSUs3,815 1,909 
The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $38.9 million and $19.7 million, respectively, as of March 31, 2026, and is expected to be recognized over the related weighted average period of 1.6 years and 2.3 years, respectively.
A summary of shares of common stock issued related to the Amended and Restated 2015 Plan, including the impact of any DERs issued in common stock, is presented below:
Three months endedThree months ended
 March 31, 2026March 31, 2025
RSUsPSUsRSUsPSUs
Shares of common stock issued301,045 177,763 273,390 121,102 
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations
(114,664)(81,876)(93,949)(53,209)
Net shares of common stock issued186,381 95,887 179,441 67,893 
Cumulative undelivered shares of common stock515,542 608,574 517,542 546,789 
Compensation Expense
The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20262025
Cost of goods sold$503 $473 
Selling, general and administrative7,635 6,070 
Research and development442 398 
Total compensation expense before income tax8,580 6,941 
Income tax benefit2,099 1,407 
Total compensation expense, net of income tax$6,481 $5,534 
v3.26.1
Accumulated Other Comprehensive Loss, Net of Tax
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Accumulated Other Comprehensive Loss, Net of Tax Accumulated Other Comprehensive Loss, Net of Tax
Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8).
The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:
 ForeignAccumulated
 ForeignExchangePension andOther
CurrencyDerivativeOtherComprehensive
(in thousands)TranslationInstrumentsPostretirementLoss, Net of Tax
Balance as of December 31, 2025$(102,533)$485 $(20,233)$(122,281)
Other comprehensive (loss) income before reclassifications(6,298)2,679 176 (3,443)
Amounts reclassified from accumulated other comprehensive loss, net of tax— 498 600 1,098 
Tax expense— (794)(183)(977)
Balance as of March 31, 2026$(108,831)$2,868 $(19,640)$(125,603)
v3.26.1
Net Income per Common Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Net Income per Common Share Net Income per Common Share
The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:
 Three months ended
 March 31,
(in thousands, except share and per share amounts)20262025
Net income attributable to Acushnet Holdings Corp.$81,416 $99,372 
Weighted average number of common shares:
Basic59,845,676 61,325,623 
RSUs163,429 159,165 
Diluted60,009,105 61,484,788 
Net income per common share attributable to Acushnet Holdings Corp.:
Basic$1.36 $1.62 
Diluted$1.36 $1.62 
Net income per common share attributable to Acushnet Holdings Corp. was calculated using the treasury stock method.
The Company’s potential dilutive securities for the three months ended March 31, 2026 and 2025 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement.
The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:
 Three months ended
 March 31,
 20262025
RSUs168,464 248,808 
v3.26.1
Segment Information
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company’s operating segments are based on how the Chief Operating Decision Maker ("CODM"), the Company's President and Chief Executive Officer, makes decisions about assessing performance and allocating resources. The Company currently has three reportable segments: (i) Titleist golf equipment, (ii) FootJoy golf wear and (iii) Golf gear.
The CODM primarily uses segment operating income (loss) to evaluate the effectiveness of business strategies, assess segment operating performance and make decisions regarding costs to incur across the business. Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the operating segments, but excludes certain other costs, such as interest expense, net; restructuring costs; the non-service cost component of net periodic benefit cost; transaction fees; as well as other items that are not allocated to the operating segments. The CODM does not evaluate a measure of assets when assessing performance.
Results shown for the three months ended March 31, 2026 and 2025 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no material intersegment transactions.
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2026
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$458,503 $181,532 $78,730 $718,765 $34,210 $752,975 
Segment expenses:
Cost of goods sold226,196 110,158 45,760 382,114 
Advertising and promotion48,489 13,158 3,431 65,078 
Research and development16,715 1,257 771 18,743 
Selling, general and administrative81,695 35,923 12,287 129,905 
Other segment items (2)
1,215 56 649 1,920 
Other expenses— — — — 35,066 
Total operating income 84,193 20,980 15,832 121,005 (856)120,149 
Reconciling items:
Interest expense, net(13,072)
Non-service cost component of net periodic benefit cost(1,570)
Other(246)
Total income before income tax$105,261 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily include identifiable intangible asset amortization expense.
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2025
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$421,092 $178,436 $70,963 $670,491 $32,881 $703,372 
Segment expenses:
Cost of goods sold206,524 104,232 40,824 351,580 
Advertising and promotion44,659 13,397 3,401 61,457 
Research and development16,344 1,310 675 18,329 
Selling, general and administrative75,269 34,927 11,649 121,845 
Other segment items (2)
2,448 55 648 3,151 
Other expenses— — — — 32,463 
Total operating income75,848 24,515 13,766 114,129 418 114,547 
Reconciling items:
Interest expense, net(13,815)
Non-service cost component of net periodic benefit cost(869)
Other (3)
20,732 
Total income before income tax$120,595 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily include identifiable intangible asset amortization expense.
(3) Other includes a non-cash gain on deconsolidation of VIE of $20.9 million (Note 16).
Information as to the Company’s operations in different geographic regions is presented below. Net sales are categorized based on the location in which the sale originates.
Three months ended March 31,
(in thousands)20262025
United States$445,161 $424,209 
EMEA (1)
124,387 103,869 
Japan36,406 35,232 
Korea61,170 66,218 
Rest of World85,851 73,844 
Total net sales$752,975 $703,372 
_______________________________________________________________________________
(1) Europe, the Middle East and Africa ("EMEA")
v3.26.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation
The Company and its subsidiaries are party to various legal proceedings associated with the normal conduct of their businesses and operations. When a loss related to a legal proceeding is probable and reasonably estimable, the Company accrues its best estimate for the ultimate resolution of the matter. While it is not possible to predict the outcome of any of these matters, the Company does not believe any currently pending legal matters will have a material adverse impact on the Company's results of operations, financial position or cash flows. Actual outcomes may differ from those expected and could have a material effect on the Company’s financial position, results of operations or cash flows in a future period.
Other Matters
In February 2026, the U.S. Supreme Court ruled that certain tariffs under the International Emergency Economic Powers Act (“IEEPA”) were invalid, and in March 2026, the U.S. Court of International Trade issued an order directing U.S. Customs and Border Protection (“CBP”) to refund duties imposed under IEEPA. In April 2026, CBP established a refund portal, allowing importers of record and authorized customs brokers to submit refund requests. The situation continues to evolve, and further legislative, regulatory, or judicial developments may affect the ultimate outcome and the availability or timing of any refunds. As of the reporting date, the Company has not recognized an asset related to any potential refunds that may be received in relation to requests that the Company has submitted. The Company will continue to evaluate new information and will recognize refunds in its financial statements when the requirements of accounting for gain contingencies under Accounting Standards Codification 450, “Contingencies”, have been met.
v3.26.1
Other Business Developments
3 Months Ended
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Other Business Developments Other Business Developments
Investment in Less than Wholly-Owned Subsidiary
During the three months ended March 31, 2026, the Company invested an additional $6.4 million in ACTPI, LLC, a less than wholly-owned subsidiary ("ACTPI"), increasing the Company's ownership interest from 80% to 84.3%. ACTPI was formed in connection with the November 4, 2022, acquisition of an 80% interest in certain assets and liabilities of TPI EDU, LLC, Onbase University, LP and Racquetfit, LP for cash consideration of $18.4 million. ACTPI educates golfers and industry professionals on the body-swing connection through its ‘TPI Certified’ program.
Supply Chain Optimization
Prior to January 31, 2025, the Company consolidated the accounts of its FootJoy manufacturing joint venture, Acushnet Lionscore Limited (“Lionscore”), a VIE which is 40% owned by the Company. During January 2025, Lionscore permanently ceased manufacturing at its Fujian Fuh Deh Leh (“FDL”) factory in Fuzhou, China and all footwear production volume was shifted to a third-party facility located in Long An Province, Vietnam (the “Long An Factory”), which is operated by an affiliate of Myre Overseas Corp. (“Myre”), the Company's Lionscore joint venture partner. As a result, the Company is no longer the primary beneficiary of Lionscore and has deconsolidated the accounts of Lionscore effective as of January 31, 2025. As such, the unaudited condensed consolidated statement of operations for the three months ended March 31, 2025 included one month of activity related to Lionscore prior to the deconsolidation. The fair value of the Company's equity interest in Lionscore as of the date of deconsolidation, determined by the appraised value of Lionscore's operating assets, was $14.1 million. In connection with the deconsolidation of Lionscore, the Company recorded a non-cash gain on deconsolidation of $20.9 million during the three months ended March 31, 2025, which was included within other expense (income), net on the unaudited condensed consolidated statement of operations. Subsequent to the deconsolidation, the Company accounts for its equity ownership interest in Lionscore under the equity method of accounting.
For the three months ended March 31, 2026 and 2025, the Company recorded a $0.1 million and $0.2 million loss respectively, related to the Lionscore equity-method investment, which was included within other expense (income), net on the unaudited condensed consolidated statements of operations. The carrying value of the Company's investment in Lionscore was $12.9 million and $13.0 million as of March 31, 2026 and December 31, 2025, respectively, which was included within other assets on the unaudited condensed consolidated balance sheets.
On January 6, 2026, Acushnet Cayman Limited, a wholly owned subsidiary of the Company (“Acushnet Cayman”), entered into a Subscription and Shareholders’ Agreement (the “JV Agreement”) with Myre and ACL FootJoy Pte. Ltd. (“ACL FootJoy”), pursuant to which Acushnet Cayman and Myre formed a joint venture and subscribed for shares in the capital of ACL FootJoy. The primary purpose of ACL FootJoy, in which the Company has a 40% interest with the remaining 60% owned by Myre, is to source raw materials for, and contract for the manufacture and production of, footwear in Vietnam, under trademarks and brand names owned by Acushnet Company ("Products") at one or more factories owned and/or controlled by Myre and/or its affiliates (the “Footwear Factories”), including the Long An Factory. Pursuant to the JV Agreement, the Company has the sole and exclusive right to purchase and distribute, and to arrange for the worldwide sale and distribution of, all Products manufactured or produced at the Footwear Factories. The Company was deemed to be the primary beneficiary due to its controlling financial interest in ACL FootJoy and as such, the Company consolidated ACL FootJoy as a VIE.
On January 28, 2026, ACL FootJoy entered into a promissory note with Lionscore, allowing ACL FootJoy to borrow up to $9.0 million to support working capital needs. The promissory note is non-interest bearing with a maturity date of January 28, 2029. As of March 31, 2026, outstanding borrowings under the promissory note of $1.5 million were included in other noncurrent liabilities on the Company's unaudited condensed consolidated balance sheet. To the extent ACL FootJoy's capital needs exceed its resources, additional funding may be provided by the Company in the form of equity or loans, however the Company is not legally obligated to provide such funding. Other than the promissory note, ACL FootJoy has no other outstanding borrowings.
PG Golf
On April 1, 2022, the Company acquired the outstanding equity interest in PG Golf LLC for $5.0 million, including cash consideration of $3.6 million and contingent consideration valued at $1.4 million at the time of acquisition. As of March 31, 2025, contingent consideration of $1.7 million was included in accrued expenses and other liabilities on the unaudited condensed consolidated balance sheet and was subsequently paid in April 2025.
v3.26.1
Restructuring Costs
3 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring Costs Restructuring Costs
Voluntary Bridge to Retirement
During the second quarter of 2025, the Company initiated a VBR program to reduce operating costs and bridge certain long-tenured eligible employees to retirement. As part of this program, eligible employees were offered severance in the form of salary and benefit continuation.
The activity related to the VBR program was as follows:
(in thousands)Three months ended March 31, 2026
Balance at beginning of period$9,855 
Decrease in provision for expected restructuring costs(114)
Payments(3,498)
Balance at end of period$6,243 
The provision for costs associated with the VBR program was included in selling, general and administrative on the unaudited condensed consolidated statement of operations. The total costs associated with the VBR program were $13.6 million. There are no further material costs expected to be incurred in relation to the VBR program. Payments are expected to continue through the first half of 2027.
The VBR program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows:
(in thousands)March 31,December 31,
Balance Sheet Location20262025
Accrued expenses and other liabilities$5,890 $9,033 
Other noncurrent liabilities353 822 
Lionscore
In 2024, Lionscore approved a plan to permanently cease manufacturing at its FDL factory and shift all footwear production volume to the Long An Factory. As a result, substantially all FDL factory employees had been involuntary separated by the first quarter of 2025.
The activity related to this plan was as follows:
(in thousands)Three months ended March 31, 2025
Balance at beginning of period$12,431 
Payments(5,439)
Deconsolidation of VIE (Note 16)
(6,992)
Balance at end of period$— 
The total employee termination costs associated with this plan was $18.0 million. There are no further costs expected to be incurred in relation to these restructuring plans. See Note 16 for further information.
v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of Acushnet Holdings Corp. (the “Company”) have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). These unaudited condensed consolidated financial statements include the accounts of the Company and Acushnet Company, including Acushnet Company's wholly-owned subsidiaries and less than wholly-owned subsidiaries, which include VIEs in which Acushnet Company is the primary beneficiary. In addition, investments in entities over which the Company has significant influence but not control are accounted for using the equity method of accounting. The Company conducts substantially all its business through Acushnet Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the SEC and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of results to be expected for the full year ending December 31, 2026, nor were those of the comparable 2025 periods representative of those actually experienced for the full year ended December 31, 2025. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2025 included in its Annual Report on Form 10-K filed with the SEC on February 27, 2026.
Use of Estimates
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities
Variable Interest Entities
VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company presents separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of consolidated VIEs that can only be used to settle specific obligations of the consolidated VIEs and the liabilities of consolidated VIEs for which creditors do not have recourse to its general credit. See Note 16 for additional information regarding other business developments impacting VIEs.
Equity Method Investments
Equity Method Investments
The Company uses the equity method of accounting for equity investments if the investment enables the Company to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in consolidated net income (loss). The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. An impairment that is other-than-temporary is recognized in the period identified. See Note 16 for additional information regarding other business developments impacting equity method investments.
Noncontrolling Interests and Redeemable Noncontrolling Interests
Noncontrolling Interests and Redeemable Noncontrolling Interests
The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations.
Foreign Currency Transactions
Foreign Currency Transactions
Foreign currency transaction (losses) gains included in selling, general and administrative expenses were losses of $1.8 million and gains of $1.4 million for the three months ended March 31, 2026 and 2025, respectively.
Recently Issued Accounting Standards
Recently Issued Accounting Standards
Expense Disaggregation Disclosures
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)." The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
Codification Improvements
In December 2025, the FASB issued ASU 2025-12, "Codification Improvements." The amendments in this update refine existing guidance to further enhance the interpretation and application of the codification. The transition method of this update may vary on an issue-by-issue basis. ASU 2025-12 is effective for annual and interim periods beginning after December 15, 2026. Early adoption is permitted on an issue-by-issue basis. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
v3.26.1
Allowance for Credit Losses (Tables)
3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Schedule of Activity Related to the Allowance for Doubtful Accounts
The activity related to the allowance for credit losses was as follows:
March 31,
(in thousands)20262025
Balance at beginning of period$7,319 $7,238 
Decrease in provision for expected credit losses(1,290)(920)
Amount of receivables (written off) recovered(149)91 
Foreign currency translation(31)124 
Balance at end of period$5,849 $6,533 
v3.26.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2026
Inventory Disclosure [Abstract]  
Schedule of Inventories
The components of inventories were as follows: 
March 31,December 31,
(in thousands)20262025
Raw materials and supplies$162,492 $145,663 
Work-in-process33,446 31,570 
Finished goods380,784 431,338 
Inventories$576,722 $608,571 
v3.26.1
Product Warranty (Tables)
3 Months Ended
Mar. 31, 2026
Product Warranties Disclosures [Abstract]  
Schedule of Warranty Obligation for Accrued Warranty Expense
The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:
 March 31,
(in thousands)20262025
Balance at beginning of period$6,062 $4,980 
Provision2,002 1,441 
Claims paid/costs incurred(1,635)(1,266)
Foreign currency translation(53)35 
Balance at end of period$6,376 $5,190 
v3.26.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets
The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:
(in thousands)March 31,December 31,
Balance Sheet LocationHedge Instrument Type20262025
Prepaid and other current assetsForeign exchange forward$4,881 $2,950 
Accrued expenses and other liabilitiesForeign exchange forward1,360 1,746 
Schedule of Effect of Hedge Instruments Losses on Accumulated Other Comprehensive Loss, Net of Tax
The hedge instrument gains (losses) recognized in accumulated other comprehensive loss, net of tax was as follows:
 Three months ended
 March 31,
(in thousands)20262025
Type of hedge  
Foreign exchange forward$2,679 $(2,160)
 Total$2,679 $(2,160)
Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations
The hedge instrument gains (losses) recognized on the unaudited condensed consolidated statements of operations were as follows:
 Three months ended
 March 31,
(in thousands)20262025
Location of gains (losses) in statements of operations  
Foreign exchange forward:
Cost of goods sold$(498)$411 
Selling, general and administrative (1)
816 (960)
Total $318 $(549)
_______________________________________________________________________________
(1) Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.
v3.26.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2026 were as follows:
 Fair Value Measurements as of 
 March 31, 2026 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$2,771 $— $— Prepaid and other current assets
Foreign exchange derivative instruments— 4,881 — Prepaid and other current assets
Deferred compensation program assets687 — — Other assets
Total assets$3,458 $4,881 $—  
Liabilities    
Foreign exchange derivative instruments$— $1,360 $— Accrued expenses and other liabilities
Deferred compensation program liabilities687 — — Other noncurrent liabilities
Total liabilities$687 $1,360 $—  
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 were as follows:
 Fair Value Measurements as of 
 December 31, 2025 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$2,906 $— $— Prepaid and other current assets
Foreign exchange derivative instruments— 2,950 — Prepaid and other current assets
Deferred compensation program assets719 — — Other assets
Total assets$3,625 $2,950 $—  
Liabilities    
Foreign exchange derivative instruments$— $1,746 $— Accrued expenses and other liabilities
Deferred compensation program liabilities719 — — Other noncurrent liabilities
Total liabilities$719 $1,746 $—  
v3.26.1
Pension and Other Postretirement Benefits (Tables)
3 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
Schedule of Components of Net Periodic Benefit Cost (Credit)
Components of net periodic benefit cost (credit) were as follows: 
 Pension BenefitsPostretirement Benefits
 Three months ended March 31,
(in thousands)2026202520262025
Components of net periodic benefit cost (credit)    
Service cost$1,045 $1,279 $89 $90 
Interest cost2,599 2,892 129 143 
Expected return on plan assets(1,758)(2,017)— — 
Settlement expense682 — — — 
Amortization of net loss (gain)100 67 (200)(237)
Amortization of prior service cost (credit)18 22 — (1)
Net periodic benefit cost (credit)$2,686 $2,243 $18 $(5)
v3.26.1
Common Stock (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Declared Dividends Per Share
The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:
Dividends per Common Share
Amount
(in thousands)
2026:
First Quarter$0.255 $15,595 
Total dividends declared in 2026$0.255 $15,595 
2025:
Fourth Quarter$0.235 $14,112 
Third Quarter0.235 14,388 
Second Quarter0.235 14,298 
First Quarter0.235 14,576 
Total dividends declared in 2025$0.940 $57,374 
Schedule of Share Repurchase Activity
The Company's share repurchase activity for the periods presented was as follows:
Three months ended March 31,
(in thousands, except share and per share amounts)20262025
Shares repurchased in the open market:
Shares repurchased 106,008 540,944 
Average price$94.12 $67.73 
Aggregate value (1)
$9,977 $36,637 
Total shares repurchased:
Shares repurchased106,008 540,944 
Average price$94.12 $67.73 
Aggregate value$9,977 $36,637 
___________________________________
(1) Includes $1.0 million related to shares repurchased not settled as of the three months ended March 31, 2025.
v3.26.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted and Performance Stock Units
A summary of the Company’s RSUs and PSUs as of March 31, 2026 and changes during the three months then ended is presented below: 
 Weighted-Weighted-
 NumberAverageNumberAverage
 of RSUsFair Value RSUs
of PSUs (3)
Fair Value PSUs
Outstanding as of December 31, 2025603,148 $65.08 500,371 $60.05 
Granted219,875 99.99 119,704 100.01 
Vested (1)(2)
(306,015)60.68 (193,351)48.21 
Forfeited(515)67.73 — — 
Outstanding as of March 31, 2026516,493 $82.55 426,724 $76.62 

_______________________________________________________________________________
(1) Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 193,351 PSUs that vested during the three months ended March 31, 2026, were entitled to receive 241,882 shares of common stock.
(2) Included 26,195 and 67,041 shares of common stock related to RSUs and PSUs, respectively, that were not delivered as of March 31, 2026.
(3) Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved.
Schedule of Shares of Common Stock Issued
Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20262025
RSUs$4,765 $5,032 
PSUs3,815 1,909 
A summary of shares of common stock issued related to the Amended and Restated 2015 Plan, including the impact of any DERs issued in common stock, is presented below:
Three months endedThree months ended
 March 31, 2026March 31, 2025
RSUsPSUsRSUsPSUs
Shares of common stock issued301,045 177,763 273,390 121,102 
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations
(114,664)(81,876)(93,949)(53,209)
Net shares of common stock issued186,381 95,887 179,441 67,893 
Cumulative undelivered shares of common stock515,542 608,574 517,542 546,789 
Schedule of Compensation Expense Related to Equity Incentive Plans
The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20262025
Cost of goods sold$503 $473 
Selling, general and administrative7,635 6,070 
Research and development442 398 
Total compensation expense before income tax8,580 6,941 
Income tax benefit2,099 1,407 
Total compensation expense, net of income tax$6,481 $5,534 
v3.26.1
Accumulated Other Comprehensive Loss, Net of Tax (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Changes in Each Component of Accumulated Comprehensive Loss, Net of Tax Effects
The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:
 ForeignAccumulated
 ForeignExchangePension andOther
CurrencyDerivativeOtherComprehensive
(in thousands)TranslationInstrumentsPostretirementLoss, Net of Tax
Balance as of December 31, 2025$(102,533)$485 $(20,233)$(122,281)
Other comprehensive (loss) income before reclassifications(6,298)2,679 176 (3,443)
Amounts reclassified from accumulated other comprehensive loss, net of tax— 498 600 1,098 
Tax expense— (794)(183)(977)
Balance as of March 31, 2026$(108,831)$2,868 $(19,640)$(125,603)
v3.26.1
Net Income per Common Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income Per Common Share
The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:
 Three months ended
 March 31,
(in thousands, except share and per share amounts)20262025
Net income attributable to Acushnet Holdings Corp.$81,416 $99,372 
Weighted average number of common shares:
Basic59,845,676 61,325,623 
RSUs163,429 159,165 
Diluted60,009,105 61,484,788 
Net income per common share attributable to Acushnet Holdings Corp.:
Basic$1.36 $1.62 
Diluted$1.36 $1.62 
Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares
The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:
 Three months ended
 March 31,
 20262025
RSUs168,464 248,808 
v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2026
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$458,503 $181,532 $78,730 $718,765 $34,210 $752,975 
Segment expenses:
Cost of goods sold226,196 110,158 45,760 382,114 
Advertising and promotion48,489 13,158 3,431 65,078 
Research and development16,715 1,257 771 18,743 
Selling, general and administrative81,695 35,923 12,287 129,905 
Other segment items (2)
1,215 56 649 1,920 
Other expenses— — — — 35,066 
Total operating income 84,193 20,980 15,832 121,005 (856)120,149 
Reconciling items:
Interest expense, net(13,072)
Non-service cost component of net periodic benefit cost(1,570)
Other(246)
Total income before income tax$105,261 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily include identifiable intangible asset amortization expense.
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2025
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$421,092 $178,436 $70,963 $670,491 $32,881 $703,372 
Segment expenses:
Cost of goods sold206,524 104,232 40,824 351,580 
Advertising and promotion44,659 13,397 3,401 61,457 
Research and development16,344 1,310 675 18,329 
Selling, general and administrative75,269 34,927 11,649 121,845 
Other segment items (2)
2,448 55 648 3,151 
Other expenses— — — — 32,463 
Total operating income75,848 24,515 13,766 114,129 418 114,547 
Reconciling items:
Interest expense, net(13,815)
Non-service cost component of net periodic benefit cost(869)
Other (3)
20,732 
Total income before income tax$120,595 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily include identifiable intangible asset amortization expense.
(3) Other includes a non-cash gain on deconsolidation of VIE of $20.9 million (Note 16).
Schedule of Net Sales By Geographical Regions
Information as to the Company’s operations in different geographic regions is presented below. Net sales are categorized based on the location in which the sale originates.
Three months ended March 31,
(in thousands)20262025
United States$445,161 $424,209 
EMEA (1)
124,387 103,869 
Japan36,406 35,232 
Korea61,170 66,218 
Rest of World85,851 73,844 
Total net sales$752,975 $703,372 
_______________________________________________________________________________
(1) Europe, the Middle East and Africa ("EMEA")
v3.26.1
Restructuring Costs (Tables)
3 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Company's Restructuring Programs
The activity related to the VBR program was as follows:
(in thousands)Three months ended March 31, 2026
Balance at beginning of period$9,855 
Decrease in provision for expected restructuring costs(114)
Payments(3,498)
Balance at end of period$6,243 
The VBR program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows:
(in thousands)March 31,December 31,
Balance Sheet Location20262025
Accrued expenses and other liabilities$5,890 $9,033 
Other noncurrent liabilities353 822 
The activity related to this plan was as follows:
(in thousands)Three months ended March 31, 2025
Balance at beginning of period$12,431 
Payments(5,439)
Deconsolidation of VIE (Note 16)
(6,992)
Balance at end of period$— 
v3.26.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Accounting Policies [Abstract]      
Loan to minority shareholders included in temporary equity $ 4.4   $ 4.4
Restricted cash 1.3   $ 1.4
Transaction gain (loss) included in selling, general and administrative expense $ (1.8) $ 1.4  
v3.26.1
Allowance for Credit Losses (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Accounts Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at beginning of period $ 7,319 $ 7,238
Decrease in provision for expected credit losses (1,290) (920)
Amount of receivables (written off) recovered (149) 91
Foreign currency translation (31) 124
Balance at end of period $ 5,849 $ 6,533
v3.26.1
Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 162,492 $ 145,663
Work-in-process 33,446 31,570
Finished goods 380,784 431,338
Inventories $ 576,722 $ 608,571
v3.26.1
Product Warranty (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Activity for accrued warranty expense    
Balance at beginning of period $ 6,062 $ 4,980
Provision 2,002 1,441
Claims paid/costs incurred (1,635) (1,266)
Foreign currency translation (53) 35
Balance at end of period $ 6,376 $ 5,190
Minimum    
Product Warranty Liability [Line Items]    
Product warranty period 1 year  
Maximum    
Product Warranty Liability [Line Items]    
Product warranty period 2 years  
v3.26.1
Debt and Financing Arrangements (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
May 02, 2024
Unsecured Local Credit Facilities      
Line of Credit Facility [Line Items]      
Weighted average interest rate (as percent) 1.37% 0.88%  
Available borrowings $ 24,800,000    
Other short-term borrowings, outstanding borrowings $ 28,000,000.0 $ 16,000,000.0  
Senior Unsecured Notes due 2028 | Unsecured Local Credit Facilities      
Line of Credit Facility [Line Items]      
Debt instrument interest rate stated percentage 5.625% 5.625%  
Amount outstanding $ 500,000,000.0 $ 500,000,000.0  
Accrued interest 9,900,000 2,900,000  
Senior Unsecured Notes due 2028 | Unsecured Local Credit Facilities | Level 2      
Line of Credit Facility [Line Items]      
Fair value of notes $ 495,800,000 505,000,000.0  
Senior Unsecured Notes Due 2033 | Unsecured Local Credit Facilities      
Line of Credit Facility [Line Items]      
Effective interest rate 5.788%    
Revolving Credit Facility      
Line of Credit Facility [Line Items]      
Maximum borrowing capacity     $ 950,000,000.0
Outstanding borrowings $ 627,600,000 $ 431,300,000  
Weighted average interest rate (as percent) 4.91% 5.06%  
Available borrowings $ 318,400,000    
Letters of credit outstanding 4,000,000.0    
Letters of Credit      
Line of Credit Facility [Line Items]      
Maximum borrowing capacity 58,800,000    
Outstanding borrowings 6,800,000 $ 6,900,000  
Line of credit secured $ 4,000,000.0 $ 4,000,000.0  
v3.26.1
Derivative Financial Instruments - Narrative (Details) - Foreign exchange forward - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Derivatives, Fair Value [Line Items]    
Expected reclassification of net gain (loss) recorded in accumulated other comprehensive gain (loss), net of tax into cost of goods sold during next twelve months $ 3.7  
Derivative Designated As Hedging    
Derivatives, Fair Value [Line Items]    
Notional amount $ 257.8 $ 230.7
Maximum    
Derivatives, Fair Value [Line Items]    
Term of derivative contract (in months) 24 months  
v3.26.1
Derivative Financial Instruments - Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets (Details) - Foreign exchange forward - Derivative Designated As Hedging - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Derivatives, Fair Value [Line Items]    
Asset derivatives $ 4,881 $ 2,950
Liability derivatives $ 1,360 $ 1,746
v3.26.1
Derivative Financial Instruments - Schedule of Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]    
 Total $ 2,679 $ (2,160)
Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
 Total 2,679 (2,160)
Foreign exchange forward | Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
 Total $ 2,679 $ (2,160)
v3.26.1
Derivative Financial Instruments - Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations (Details) - Derivative Designated As Hedging - Foreign exchange forward - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ 318 $ (549)
Cost of goods sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ (498) $ 411
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of goods sold Cost of goods sold
Selling, general and administrative    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ 816 $ (960)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Selling, general and administrative Selling, general and administrative
v3.26.1
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Level 1    
Assets    
Rabbi trust $ 2,771 $ 2,906
Foreign exchange derivative instruments 0 0
Deferred compensation program assets 687 719
Total assets 3,458 3,625
Liabilities    
Foreign exchange derivative instruments 0 0
Deferred compensation program liabilities 687 719
Total liabilities 687 719
Level 2    
Assets    
Rabbi trust 0 0
Foreign exchange derivative instruments 4,881 2,950
Deferred compensation program assets 0 0
Total assets 4,881 2,950
Liabilities    
Foreign exchange derivative instruments 1,360 1,746
Deferred compensation program liabilities 0 0
Total liabilities 1,360 1,746
Level 3    
Assets    
Rabbi trust 0 0
Foreign exchange derivative instruments 0 0
Deferred compensation program assets 0 0
Total assets 0 0
Liabilities    
Foreign exchange derivative instruments 0 0
Deferred compensation program liabilities 0 0
Total liabilities $ 0 $ 0
v3.26.1
Pension and Other Postretirement Benefits (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Pension Benefits    
Components of net periodic benefit cost (credit)    
Service cost $ 1,045 $ 1,279
Interest cost 2,599 2,892
Expected return on plan assets (1,758) (2,017)
Settlements 682 0
Amortization of net loss (gain) 100 67
Amortization of prior service cost (credit) 18 22
Net periodic benefit cost (credit) 2,686 2,243
Postretirement Benefits    
Components of net periodic benefit cost (credit)    
Service cost 89 90
Interest cost 129 143
Expected return on plan assets 0 0
Settlements 0 0
Amortization of net loss (gain) (200) (237)
Amortization of prior service cost (credit) 0 (1)
Net periodic benefit cost (credit) $ 18 $ (5)
v3.26.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]    
Increase (decrease) in income tax expense $ 2,500  
Income tax expense $ 24,101 $ 21,570
Effective tax rate (as percent) 22.90% 17.90%
v3.26.1
Common Stock - Schedule of Declared Dividends Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2025
Equity [Abstract]            
Dividends per Common Share (in dollars per share) $ 0.255 $ 0.235 $ 0.235 $ 0.235 $ 0.235 $ 0.940
Amount $ 15,595 $ 14,112 $ 14,388 $ 14,298 $ 14,576 $ 57,374
v3.26.1
Common Stock - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 10, 2025
Apr. 10, 2025
Dec. 17, 2024
May 06, 2026
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2025
Jun. 14, 2024
Dividends Payable [Line Items]                      
Dividends per Common Share (in dollars per share)         $ 0.255 $ 0.235 $ 0.235 $ 0.235 $ 0.235 $ 0.940  
Issued and outstanding common stock authorized to repurchase         $ 1,250,000,000            
Aggregate value         9,977,000       $ 36,637,000    
Satisfaction of obligation under agreement         230,700,000            
Subsequent Event                      
Dividends Payable [Line Items]                      
Dividends per Common Share (in dollars per share)       $ 0.255              
Treasury Stock                      
Dividends Payable [Line Items]                      
Aggregate value         $ 10,000,000.0            
Treasury share retirement (in shares)         106,008            
Magnus                      
Dividends Payable [Line Items]                      
Stock repurchase program, authorized amount                     $ 62,500,000
Accrued share repurchase (in shares) 953,406 935,907                  
Aggregate value $ 62,500,000 $ 62,500,000 $ 62,500,000                
v3.26.1
Common Stock - Schedule of Share Repurchase Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dividends Payable [Line Items]    
Shares repurchased (in shares) 106,008 540,944
Average price (in dollars per share) $ 94.12 $ 67.73
Aggregate value $ 9,977 $ 36,637
Open Market    
Dividends Payable [Line Items]    
Shares repurchased (in shares) 106,008 540,944
Average price (in dollars per share) $ 94.12 $ 67.73
Aggregate value $ 9,977 $ 36,637
Treasury stock, value repurchased not settled   $ 1,000
v3.26.1
Equity Incentive Plans - Narrative (Details)
$ in Millions
3 Months Ended
Mar. 31, 2026
USD ($)
shares
RSUs | Officers, Employees, Consultants and Advisors  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period (in years) 3 years
Vesting percentage 33.33%
PSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Performance period (in years) 3 years
PSUs | Officers, Employees, Consultants and Advisors | Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 0.00%
PSUs | Officers, Employees, Consultants and Advisors | Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 200.00%
2015 Omnibus Incentive Plan | RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation expense | $ $ 38.9
Weighted average period (in years) 1 year 7 months 6 days
2015 Omnibus Incentive Plan | PSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation expense | $ $ 19.7
Weighted average period (in years) 2 years 3 months 18 days
Common Stock | Amended and Restated 2015 Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based compensation, number of shares available for grant (in shares) | shares 5,725,693
Common stock, capital shares reserved for future issuance (in shares) | shares 3,120,170
v3.26.1
Equity Incentive Plans - Schedule of Restricted and Performance Stock Units (Details) - 2015 Omnibus Incentive Plan
3 Months Ended
Mar. 31, 2026
$ / shares
shares
RSUs  
Number of Units  
Outstanding at beginning of the period (in shares) 603,148
Granted (in shares) 219,875
Vested (in shares) (306,015)
Forfeited (in shares) (515)
Outstanding at end of the period (in shares) 516,493
Weighted - Average Fair Value  
Outstanding at beginning of the period (in dollars per share) | $ / shares $ 65.08
Granted (in dollars per share) | $ / shares 99.99
Vested (in dollars per share) | $ / shares 60.68
Forfeited (in dollars per share) | $ / shares 67.73
Outstanding at end of the period (in dollars per share) | $ / shares $ 82.55
Undelivered (in shares) 26,195
Vested (in shares) 306,015
PSUs  
Number of Units  
Outstanding at beginning of the period (in shares) 500,371
Granted (in shares) 119,704
Vested (in shares) (193,351)
Forfeited (in shares) 0
Outstanding at end of the period (in shares) 426,724
Weighted - Average Fair Value  
Outstanding at beginning of the period (in dollars per share) | $ / shares $ 60.05
Granted (in dollars per share) | $ / shares 100.01
Vested (in dollars per share) | $ / shares 48.21
Forfeited (in dollars per share) | $ / shares 0
Outstanding at end of the period (in dollars per share) | $ / shares $ 76.62
Vested (in shares) 193,351
Achieved target level of performance (in percent) 100.00%
PSUs | Common Stock  
Number of Units  
Vested (in shares) (67,041)
Weighted - Average Fair Value  
Undelivered (in shares) 241,882
Vested (in shares) 67,041
v3.26.1
Equity Incentive Plans - Schedule of Compensation Expense Recorded in the Consolidated Statement of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense $ 8,580 $ 6,941
RSUs | 2015 Omnibus Incentive Plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense 4,765 5,032
PSUs | 2015 Omnibus Incentive Plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense $ 3,815 $ 1,909
v3.26.1
Equity Incentive Plans - Schedule of Shares of Common Stock Issued (Details) - 2015 Omnibus Incentive Plan - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
RSUs    
Class of Stock [Line Items]    
Cumulative undelivered shares of common stock (in shares) 26,195  
Common Stock | RSUs    
Class of Stock [Line Items]    
Shares of common stock issued (in shares) 301,045 273,390
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) (114,664) (93,949)
Net shares of common stock issued (in shares) 186,381 179,441
Cumulative undelivered shares of common stock (in shares) 515,542 517,542
Common Stock | PSUs    
Class of Stock [Line Items]    
Shares of common stock issued (in shares) 177,763 121,102
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) (81,876) (53,209)
Net shares of common stock issued (in shares) 95,887 67,893
Cumulative undelivered shares of common stock (in shares) 608,574 546,789
v3.26.1
Equity Incentive Plans - Schedule of Compensation Expense Related to Equity Incentive Plans (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax $ 8,580 $ 6,941
Income tax benefit 2,099 1,407
Total compensation expense, net of income tax 6,481 5,534
Cost of goods sold    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax 503 473
Selling, general and administrative    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax 7,635 6,070
Research and development    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax $ 442 $ 398
v3.26.1
Accumulated Other Comprehensive Loss, Net of Tax (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance $ 783,566
Ending balance 825,035
Accumulated Other Comprehensive Loss, Net of Tax  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance (122,281)
Other comprehensive (loss) income before reclassifications (3,443)
Amounts reclassified from accumulated other comprehensive loss, net of tax 1,098
Tax expense (977)
Ending balance (125,603)
Foreign Currency Translation  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance (102,533)
Other comprehensive (loss) income before reclassifications (6,298)
Amounts reclassified from accumulated other comprehensive loss, net of tax 0
Tax expense 0
Ending balance (108,831)
Gains (Losses) on Derivative Instruments | Foreign Exchange Derivative Instruments  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance 485
Other comprehensive (loss) income before reclassifications 2,679
Amounts reclassified from accumulated other comprehensive loss, net of tax 498
Tax expense (794)
Ending balance 2,868
Pension and Other Postretirement  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance (20,233)
Other comprehensive (loss) income before reclassifications 176
Amounts reclassified from accumulated other comprehensive loss, net of tax 600
Tax expense (183)
Ending balance $ (19,640)
v3.26.1
Net Income per Common Share - Schedule of Computation of Basic and Diluted Net Income Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net income attributable to Acushnet Holdings Corp. $ 81,416 $ 99,372
Weighted average number of common shares:    
Basic (in shares) 59,845,676 61,325,623
Diluted (in shares) 60,009,105 61,484,788
Net income per common share attributable to Acushnet Holdings Corp.:    
Basic (in dollars per share) $ 1.36 $ 1.62
Diluted (in dollars per share) $ 1.36 $ 1.62
RSUs    
Weighted average number of common shares:    
Basic (in shares) 163,429 159,165
v3.26.1
Net Income per Common Share - Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
RSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computation of earnings per share (in shares) 168,464 248,808
v3.26.1
Segment Information - Reconciliation (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
segment
Segment Reporting [Abstract]    
Number of reportable segments | segment 3  
Segment Reporting Information [Line Items]    
Net sales $ 752,975 $ 703,372
Segment expenses:    
Cost of goods sold 397,715 366,210
Research and development 19,195 18,859
Selling, general and administrative 213,671 200,261
Income from operations 120,149 114,547
Reconciling items:    
Interest expense, net (13,072) (13,815)
Income before income taxes $ 105,261 $ 120,595
Number of non-reportable segments | segment 2 2
Deconsolidation of VIE (Note 16) $ 0 $ 20,887
VIE    
Reconciling items:    
Deconsolidation of VIE (Note 16)   20,900
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 718,765 670,491
Segment expenses:    
Cost of goods sold 382,114 351,580
Advertising and promotion 65,078 61,457
Research and development 18,743 18,329
Selling, general and administrative 129,905 121,845
Other segment items 1,920 3,151
Other expenses 0 0
Income from operations 121,005 114,129
Other    
Segment Reporting Information [Line Items]    
Net sales 34,210 32,881
Segment expenses:    
Other expenses 35,066 32,463
Income from operations (856) 418
Reconciling Items    
Reconciling items:    
Interest expense, net (13,072) (13,815)
Non-service cost component of net periodic benefit cost (1,570) (869)
Other (246) 20,732
Titleist Golf Equipment | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 458,503 421,092
Segment expenses:    
Cost of goods sold 226,196 206,524
Advertising and promotion 48,489 44,659
Research and development 16,715 16,344
Selling, general and administrative 81,695 75,269
Other segment items 1,215 2,448
Other expenses 0 0
Income from operations 84,193 75,848
FootJoy Golf Wear | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 181,532 178,436
Segment expenses:    
Cost of goods sold 110,158 104,232
Advertising and promotion 13,158 13,397
Research and development 1,257 1,310
Selling, general and administrative 35,923 34,927
Other segment items 56 55
Other expenses 0 0
Income from operations 20,980 24,515
Golf Gear | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 78,730 70,963
Segment expenses:    
Cost of goods sold 45,760 40,824
Advertising and promotion 3,431 3,401
Research and development 771 675
Selling, general and administrative 12,287 11,649
Other segment items 649 648
Other expenses 0 0
Income from operations $ 15,832 $ 13,766
v3.26.1
Segment Information - Schedule of Net Sales By Geographical Regions (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales $ 752,975 $ 703,372
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 445,161 424,209
EMEA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 124,387 103,869
Japan    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 36,406 35,232
Korea    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 61,170 66,218
Rest of World    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales $ 85,851 $ 73,844
v3.26.1
Other Business Developments (Details) - USD ($)
$ in Thousands
3 Months Ended
Jan. 30, 2025
Nov. 04, 2022
Apr. 01, 2022
Mar. 31, 2026
Mar. 31, 2025
Mar. 30, 2026
Jan. 28, 2026
Jan. 06, 2026
Dec. 31, 2025
Feb. 01, 2025
Business Combination [Line Items]                    
Additional investment in less than wholly-owned subsidiary (Note 16)       $ 6,361 $ 0          
Deconsolidation of VIE (Note 16)       0 20,887          
Loss from equity method investment (Note 16)       66 223          
PG Golf LLC                    
Business Combination [Line Items]                    
Cash consideration     $ 3,600              
Purchase price     5,000              
Contingent consideration     $ 1,400   1,700          
Corporate Joint Venture | ACL FootJoy                    
Business Combination [Line Items]                    
Debt instrument, face amount             $ 9,000      
Notes payable       1,500            
ACL FootJoy | Corporate Joint Venture                    
Business Combination [Line Items]                    
Ownership percentage               40.00%    
ACL FootJoy | Corporate Joint Venture | Myre                    
Business Combination [Line Items]                    
Ownership percentage               60.00%    
VIE                    
Business Combination [Line Items]                    
Ownership percentage 40.00%                  
Deconsolidation of VIE (Note 16)         20,900          
ACTPI LLC | ACTPI LLC                    
Business Combination [Line Items]                    
Additional investment in less than wholly-owned subsidiary (Note 16)       $ 6,400            
Ownership interest, percentage       84.30%   80.00%        
Percent of certain assets and liabilities acquired   80.00%                
Cash consideration   $ 18,400                
Lionscore                    
Business Combination [Line Items]                    
Investment at fair value       $ 12,900         $ 13,000 $ 14,100
Loss from equity method investment (Note 16)       $ 100 $ 200          
v3.26.1
Restructuring Costs - Schedule of Company's Restructuring Program Rollforward (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Restructuring Reserve [Roll Forward]    
Deconsolidation of VIE (Note 16) $ 0 $ 20,887
Employee Severance | VBR    
Restructuring Reserve [Roll Forward]    
Balance at beginning of period 9,855  
Decrease in provision for expected restructuring costs (114)  
Payments (3,498)  
Balance at end of period $ 6,243  
Facility Closing | Initial Plan    
Restructuring Reserve [Roll Forward]    
Balance at beginning of period   12,431
Payments   (5,439)
Deconsolidation of VIE (Note 16)   (6,992)
Balance at end of period   $ 0
v3.26.1
Restructuring Costs - Narrative (Details)
3 Months Ended
Mar. 31, 2026
USD ($)
VBR | Employee Severance  
Restructuring Cost and Reserve [Line Items]  
Restructuring charges $ 13,600,000
Initial Plan | Employee Severance  
Restructuring Cost and Reserve [Line Items]  
Restructuring and related cost, incurred cost 18,000,000.0
Initial Plan | Facility Closing  
Restructuring Cost and Reserve [Line Items]  
Expected remaining cost $ 0
v3.26.1
Restructuring Costs - Restructuring Liabilities Recognized on Balance Sheet (Details) - Employee Severance - VBR - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Restructuring Cost and Reserve [Line Items]    
Restructuring reserve, current $ 5,890 $ 9,033
Restructuring reserve, noncurrent $ 353 $ 822